Royal Philips to Acquire BioTelemetry, Inc. for $2.8B

December 18, 2020

Royal Philips has agreed to acquire BioTelemetry, Inc. in a cash tender offer of USD 72.00 per share, implying an enterprise value of approximately USD 2.8 billion. The deal combines Philips' hospital patient-monitoring capabilities with BioTelemetry's remote cardiac diagnostics and monitoring services (which serve over 1 million patients annually and had 2019 sales of about USD 439 million) to expand Philips' patient care management offerings across hospital and home settings.

Buyers
Royal Philips
Targets
BioTelemetry, Inc.
Location
Pennsylvania, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.